STRO logo

STRO
Sutro Biopharma Inc

1,120
Mkt Cap
$606.69M
Volume
58,797.00
52W High
$39.10
52W Low
$6.74
PE Ratio
-1.62
STRO Fundamentals
Price
$35.79
Prev Close
$36.62
Open
$36.73
50D MA
$25.65
Beta
1.45
Avg. Volume
204,104.00
EPS (Annual)
-$22.49
P/B
-2.37
Rev/Employee
$748,058.39
$192.10
Loading...
Loading...
News
all
press releases
Sutro Biopharma (NASDAQ:STRO) Upgraded by Mizuho to "Strong-Buy" Rating
Mizuho upgraded shares of Sutro Biopharma to a "strong-buy" rating in a report on Thursday...
MarketBeat·5h ago
News Placeholder
More News
News Placeholder
Short Interest in Sutro Biopharma, Inc. (NASDAQ:STRO) Grows By 17.0%
Sutro Biopharma, Inc. (NASDAQ:STRO - Get Free Report) was the recipient of a significant increase in short interest during the month of April. As of April 15th, there was short interest totaling...
MarketBeat·1d ago
News Placeholder
Sutro Biopharma (NASDAQ:STRO) Hits New 1-Year High - What's Next?
Sutro Biopharma (NASDAQ:STRO) Reaches New 12-Month High - Still a Buy...
MarketBeat·2d ago
News Placeholder
Sutro Biopharma (NASDAQ:STRO) Shares Up 5.6% - What's Next?
Sutro Biopharma (NASDAQ:STRO) Shares Up 5.6% - Still a Buy...
MarketBeat·3d ago
News Placeholder
Sutro Biopharma (NASDAQ:STRO) Shares Gap Down - What's Next?
Sutro Biopharma (NASDAQ:STRO) Shares Gap Down - Should You Sell...
MarketBeat·4d ago
News Placeholder
Sutro Biopharma (NASDAQ:STRO) Shares Down 6.1% - Time to Sell?
Sutro Biopharma (NASDAQ:STRO) Trading Down 6.1% - What's Next...
MarketBeat·7d ago
News Placeholder
Citizens Jmp Boosts Sutro Biopharma (NASDAQ:STRO) Price Target to $41.00
Citizens Jmp raised their target price on Sutro Biopharma from $35.00 to $41.00 and gave the stock a "market outperform" rating in a research note on Thursday...
MarketBeat·8d ago
News Placeholder
Sutro Biopharma (NASDAQ:STRO) Reaches New 1-Year High - Still a Buy?
Sutro Biopharma (NASDAQ:STRO) Reaches New 1-Year High - Here's What Happened...
MarketBeat·10d ago
News Placeholder
Sutro Biopharma, Inc. $STRO Shares Sold by JPMorgan Chase & Co.
JPMorgan Chase & Co. lowered its position in shares of Sutro Biopharma, Inc. (NASDAQ:STRO - Free Report) by 56.1% in the third quarter, according to the company in its most recent Form 13F filing...
MarketBeat·10d ago
News Placeholder
Sutro Biopharma, Inc. (NASDAQ:STRO) Short Interest Up 20.1% in March
Sutro Biopharma, Inc. (NASDAQ:STRO - Get Free Report) saw a significant growth in short interest during the month of March. As of March 31st, there was short interest totaling 639,714 shares, a...
MarketBeat·14d ago
<
1
2
...
>

Latest STRO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.